I do agree Iwonder.
Look at Medlab with there nanocelle delivery method, nanabis product and the time these things take. Yes they had cash flows last qtr, $498 maybe they will beat it next qtr?
- Forums
- ASX - By Stock
- CGB
- Ann: MCL Implementing Canntab Drug Development Strategy
Ann: MCL Implementing Canntab Drug Development Strategy, page-9
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online